search
en
Below you’ll find press releases covering our financial news. For the latest on our products, solutions and business units, including insights into the latest trends, please go to our Newsroom.
Mar 27, 2025
— Dividend proposal of € 1.20 per share (2023: € 1.10) – 15th increase in succession — Symrise confirms targets for 2025: Organic growth of 5-7 % — Profitability (EBITDA margin) of around 21 % expected — Executive Board contract of Dr. Stephanie Cossmann extended ahead of schedule until January 2030
February 2026
Corporate | Financial | Investors February 9, 2026
American Authorities closing ongoing Antitrust Investigation against Symrise
The Department of Justice of the United States of America (“DoJ”) has informed Symrise by a letter dated February 5th, 2026, that it is closing its investigation against Symrise.
No unlawful practice of Symrise has been found. Symrise welcomes the decision by the DoJ. The company has always maintained that it did not participate in any unlawful agreements with…
Taste, Nutrition & Health | Scent & Care | Corporate | Financial | Sustainability February 3, 2026
CDP recognizes Symrise for sustainability results
– Symrise scores A- for Climate, A- for Water and B for Forest in 2025 CDP Ratings
– Result reflects high level of transparency and constant sustainability dedication
– Symrise demonstrates commitment to reducing environmental impacts
January 2026
Corporate | Financial January 12, 2026
Symrise AG Announces Inaugural Share Buy-back Program
— Supervisory Board authorizes repurchase of shares up to EUR 400 million
— The program will be active between 1 February and 31 October, 2026
Ad hoc January 12, 2026
Symrise AG resolves a share buy-back program in the amount of EUR 400 million
Symrise AG / Key word(s): Share Buyback Symrise AG resolves a share buy-back program in the amount of EUR 400 million 12-Jan-2026 / 20:07 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of
Ad hoc January 12, 2026
Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.
Symrise AG / Key word(s): Miscellaneous Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment. 12-Jan-2026 / 19:27 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the
Head of Investor Relations
Investor Relations
